RhumbLine Advisers’s Allergan Inc AGN Stock Holding History

RhumbLine Advisers’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-505,563	Closed	-$107M	–	3086
2014 Q4	$107M	Sell	505,563 -12,834	-2%	-$2.55M	0.31%	67
2014 Q3	$92.4M	Sell	518,397 -8,482	-2%	-$1.41M	0.28%	80
2014 Q2	$89.2M	Sell	526,879 -19,505	-4%	-$3.04M	0.26%	85
2014 Q1	$67.8M	Sell	546,384 -9,730	-2%	-$1.18M	0.2%	105
2013 Q4	$61.8M	Sell	556,114 -42,149	-7%	-$4.03M	0.18%	120
2013 Q3	$54.1M	Sell	598,263 -12,393	-2%	-$1.11M	0.17%	129
2013 Q2	$51.4M	Buy	+610,656	New	+$63.4M	0.17%	125

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

RhumbLine Advisers's AGN Position: Q1 2015 in Review

RhumbLine Advisers sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 505,563 shares — an estimated $107M sold.

RhumbLine Advisers first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $107M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

RhumbLine Advisers reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
RhumbLine Advisers sold 505,563 Allergan Inc shares in Q1 2015, an estimated $107M.
RhumbLine Advisers first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
RhumbLine Advisers's Allergan Inc position peaked at $107M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.